Search Results 1651-1660 of 16204 for Epilepsy (Partial Onset)
- Disease duration from the onset of MS symptoms of <15 years if screening EDSS score of >5.0 OR <10 years if screening EDSS score of ≤5.0. - Positive ...
The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit ...
NOTE: Patients previously treated or untreated for this condition who are asymptomatic in the absence of corticosteroid and anti-epileptic therapy are allowed.
More than 180 radiologists and physicists cooperate with 1,100 support staff to provide diagnostic and therapeutic radiology services, including SPECT imaging, ...
The total duration of this study will be approximately 62 weeks, consisting of a 1 to 2 week screening period, 52-week treatment period and 8-week follow-up ...
Through research into the power of proton beams, Mayo Clinic experts are finding ways to reduce breast cancer treatment to between three and five fractions and ...
Science Saturday: Brainstorming on epilepsy. Dana Sparks. November 3, 2018. Science Saturday: Thinking small for big possibilities. Mayo Clinic Staff. June 23 ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial ... epilepsy. A ...
... duration, or their physician's over-riding guidance. Patients who are unable to tolerate this dosing regimen for 90 days, or those in whom NSAIDS or ...
This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.